Hi Bruce,
this is true, but I noticed that many papers used TIV as a covariate. In
addition, in my samples (both pathological and healthy) there is a
moderate positive correlation between gyrification and TIV (and brain
volume). For the hemispheric overall gyrification index the correlation is
0.3-0.35 with TIV and 0.35-0.4 with total brain volume.
I think that in pathological samples with possible brain atrophy, this is
a way to control for a possible bias effect. Am I wrong?

Thank you
Angela

> Hi Angela
>
> gyrification is the ratio of areas and hence dimensionless, so I would
> think it wouldn't be much affected by TIV.
>
> cheers
> Bruce
>
>
> On Sun, 21 Feb 2016, angela.fav...@unipd.it wrote:
>
>> In the case of a gyrification analysis, does correction for total brain
>> volume make sense?
>>
>> Angela
>>
>> Inviato dal mio dispositivo Huawei
>>
>> -------- Messaggio originale --------
>> Oggetto: Re: [Freesurfer] eTIV question
>> Da: Bruce Fischl
>> A: Freesurfer support list
>> CC:
>>
>>
>>       yes, it's a somewhat different and more conservative test. I
>>       guess you
>>       could check the talairach transforms of some of your subjects
>>       with eTIVs
>>       that don't make sense (or change the most over time) to try to
>>       see why
>>       this is happening. Or take Mike's suggestion and test a
>>       different (but
>>       probably still interesting) hypothesis
>>
>>       On Sun, 21 Feb 2016, Angela Favaro wrote:
>>
>>       > Hi, thank you
>>       > I think this would test something different: 'how much a brain
>>       area is
>>       > atrophic controlling for the average brain atrophy' and not
>>       'how much
>>       > a brain area is atrophic controlling for the individual
>>       differences in
>>       > head size'. Doesn't it?
>>       >
>>       > Angela
>>       >
>>       >
>>       > "Harms, Michael" ha scritto:
>>       >
>>       >> Hi,
>>       >> Why not use a measurement of brain size rather than “eTIV”?
>>       >>
>>       >> cheers,
>>       >> -MH
>>       >>
>>       >> --
>>       >> Michael Harms, Ph.D.
>>       >>
>>       >> -----------------------------------------------------------
>>       >> Conte Center for the Neuroscience of Mental Disorders
>>       >> Washington University School of Medicine
>>       >> Department of Psychiatry, Box 8134
>>       >> 660 South Euclid Ave.Tel: 314-747-6173
>>       >> St. Louis, MO 63110Email: mha...@wustl.edu
>>       >>
>>       >>
>>       >>
>>       >>
>>       >> On 2/21/16, 6:06 AM, "freesurfer-boun...@nmr.mgh.harvard.edu
>>       on behalf of
>>       >> Angela Favaro" >> angela.fav...@unipd.it> wrote:
>>       >>
>>       >> there is a mistake in the graph, hippocampal volume is TIV2
>>       >> I apologize for that!
>>       >>
>>       >> Angela Favaro ha scritto:
>>       >>
>>       >>> Hi Bruce,
>>       >>> please find attached the graph of the correlation between
>>       the two time
>>       >>> point. I did not find outliers or failures. However the
>>       discrepancy
>>       >>> between TIVs is particularly high in few cases. Obviously
>>       these data
>>       >>> are those before running longitudinal streaming
>>       >>> This is a sample of adolescents with low body weight
>>       (anorexia nervosa).
>>       >>> In my previous study (on young adults with low weight) I
>>       found no
>>       >>> correlation between TIV and body weight and high
>>       correlations between
>>       >>> fs estimated TIV and manually segmented TIV (r=0.94 in the
>>       whole
>>       >>> sample and r=0.93 in the underweight sample (n=38)).
>>       >>> Do you think that the young age can be a factor? or patients
>>       who are
>>       >>> more acutely underweight?
>>       >>> Thank you for any suggestion
>>       >>>
>>       >>> Angela
>>       >>>
>>       >>>
>>       >>> Bruce Fischl ha scritto:
>>       >>>
>>       >>>> Hi Angel
>>       >>>>
>>       >>>> the time1/time2 correlation of eTIV is pretty worrisome.
>>       Are you sure
>>       >>>> that there aren't outliers/failures in that set?
>>       >>>>
>>       >>>> Bruce
>>       >>>>
>>       >>>>
>>       >>>> On Sun, 14 Feb 2016, angela.fav...@unipd.it wrote:
>>       >>>>
>>       >>>>> Dear Freesurfer experts,
>>       >>>>> I have a question about eTIV (FS 5.3) which I use as a
>>       covariate where
>>       >>>>> appropriate. Is it in some way influenced by the presence
>>       of brain
>>       >>>>> atrophy?
>>       >>>>> I have a new sample of subjects in a longitudinal study:
>>       at time 1 they
>>       >>>>> have some atrophy (due to low body weight) that improves
>>       in time 2 (4
>>       >>>>> months). I observed that eTIV-time1 is slightly correlated
>>       with weight
>>       >>>>> (r=0.3) whereas no correlation is present at time 2. The
>>       correlation
>>       >>>>> between eTIV-time1 and eTIV-time2 is somewhat lower than
>>       expected
>>       >>>>> (r=0.53)
>>       >>>>> and is lower than correlation between SegBrain_Vol_1 and
>>       SegBrain_Vol_2
>>       >>>>> (0.65).
>>       >>>>>
>>       >>>>> Do you suggest in these cases to perform manual
>>       segmentation to obtain
>>       >>>>> TIV? or is there any other method (in freesurfer) to
>>       obtain an
>>       >>>>> estimate of
>>       >>>>> TIV not influenced by brain atrophy? What about using
>>       BrainMask_to_TIV?
>>       >>>>>
>>       >>>>> Thank you for any suggestion
>>       >>>>>
>>       >>>>> Angela
>>       >>>>>
>>       >>>>>
>>       >>>>> _______________________________________________
>>       >>>>> Freesurfer mailing list
>>       >>>>> Freesurfer@nmr.mgh.harvard.edu
>>       >>>>>
>>       https://mail.nmr.mgh.harvard.edu/mailman/listinfo/freesurfer
>>       >>>>>
>>       >>>>>
>>       >>>>>
>>       >>>> _______________________________________________
>>       >>>> Freesurfer mailing list
>>       >>>> Freesurfer@nmr.mgh.harvard.edu
>>       >>>>
>>       https://mail.nmr.mgh.harvard.edu/mailman/listinfo/freesurfer
>>       >>>>
>>       >>>>
>>       >>>> The information in this e-mail is intended only for the
>>       person to whom
>>       >>>> it is
>>       >>>> addressed. If you believe this e-mail was sent to you in
>>       error and
>>       >>>> the e-mail
>>       >>>> contains patient information, please contact the Partners
>>       Compliance
>>       >>>> HelpLine at
>>       >>>> http://www.partners.org/complianceline . If the e-mail was
>>       sent to
>>       >>>> you in error
>>       >>>> but does not contain patient information, please contact
>>       the sender
>>       >>>> and properly
>>       >>>> dispose of the e-mail.
>>       >>
>>       >>
>>       >>
>>       >> _______________________________________________
>>       >> Freesurfer mailing list
>>       >> Freesurfer@nmr.mgh.harvard.edu
>>       >> https://mail.nmr.mgh.harvard.edu/mailman/listinfo/freesurfer
>>       >>
>>       >>
>>       >> ________________________________
>>       >> The materials in this message are private and may contain
>>       Protected
>>       >> Healthcare Information or other information of a sensitive
>>       nature.
>>       >> If you are not the intended recipient, be advised that any
>>       >> unauthorized use, disclosure, copying or the taking of any
>>       action in
>>       >> reliance on the contents of this information is strictly
>>       prohibited.
>>       >> If you have received this email in error, please immediately
>>       notify
>>       >> the sender via telephone or return mail.
>>       >>
>>       >> _______________________________________________
>>       >> Freesurfer mailing list
>>       >> Freesurfer@nmr.mgh.harvard.edu
>>       >> https://mail.nmr.mgh.harvard.edu/mailman/listinfo/freesurfer
>>       >
>>       >
>>       >
>>       >
>>       > _______________________________________________
>>       > Freesurfer mailing list
>>       > Freesurfer@nmr.mgh.harvard.edu
>>       > https://mail.nmr.mgh.harvard.edu/mailman/listinfo/freesurfer
>>       >
>>       >
>>       >
>>       _______________________________________________
>>       Freesurfer mailing list
>>       Freesurfer@nmr.mgh.harvard.edu
>>       https://mail.nmr.mgh.harvard.edu/mailman/listinfo/freesurfer
>>
>>
>>       The information in this e-mail is intended only for the person
>>       to whom it is
>>       addressed. If you believe this e-mail was sent to you in error
>>       and the e-mail
>>       contains patient information, please contact the Partners
>>       Compliance HelpLine at
>>       http://www.partners.org/complianceline . If the e-mail was sent
>>       to you in error
>>       but does not contain patient information, please contact the
>>       sender and properly
>>       dispose of the e-mail.
>>
>>
>>_______________________________________________
> Freesurfer mailing list
> Freesurfer@nmr.mgh.harvard.edu
> https://mail.nmr.mgh.harvard.edu/mailman/listinfo/freesurfer
>
>
> The information in this e-mail is intended only for the person to whom it
> is
> addressed. If you believe this e-mail was sent to you in error and the
> e-mail
> contains patient information, please contact the Partners Compliance
> HelpLine at
> http://www.partners.org/complianceline . If the e-mail was sent to you in
> error
> but does not contain patient information, please contact the sender and
> properly
> dispose of the e-mail.
>



_______________________________________________
Freesurfer mailing list
Freesurfer@nmr.mgh.harvard.edu
https://mail.nmr.mgh.harvard.edu/mailman/listinfo/freesurfer

Reply via email to